CTRI/2017/06/008950进行中（未招募）未知
A Study to Evaluate the Efficacy and Safety of Metaderm M1 and Metaderm M5 Cream Formulas in Patients with Moderate to Severe Atopic Dermatitis - NI
试验速览
- 阶段
- 未知
- 状态
- 进行中（未招募）
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1) Moderate to severe atopic dermatitis as determined by Physicianâ??s Global Assessment (PGA > 3) and SCORAD > 25 (SCORAD and PGA will incorporate whole body assessments)
- •2)Males and females, age 12 - 65 years old inclusive
排除标准
- •1) Is currently participating or has participated in another interventional clinical study at this or any other facility in the past 3 months.
- •2) Currently or has been diagnosed/treated for cancer in the past 5 years.
- •3) Requires any topical or systemic medications that could affect the course of their atopic dermatitis during the study period (except inhaled steroids and/or antihistamines for asthma or allergies).
- •4) Has a known hypersensitivity to any corticosteroid creams.
- •5) Has any active infections or has used antibiotics in the past 7 days.
- •6) Has any physical attributes or skin conditions that might interfere with the clear visual or instrumental assessments.(i.e. cuts, sunburn, birth marks, tattoos, extensive scarring, excessive hair growth or acne)
- •7) Has an immunologic or infectious disease (e.g. hepatitis, tuberculosis, HIV or AIDS, lupus rheumatoid arthritis) which could place the subject at risk or interfere with the accuracy of the
- •study results.
- •8)Has used any immunosuppressant drugs or immunotherapy within the past 30 days or 5 half-lives.
- •9) Is an employee of the sponsor company or clinical testing site.
- •10) Is dependent on oral medication for any skin disease/condition or could not, in the opinion of the Investigator tolerate the restriction of discontinuing the medicine as required in this study.
- •11)Is currently pregnant or lactating or planning to become pregnant in the next 6 months (using double contraception for prevention).
- •12)Any other condition or factor the Investigator or their duly assigned representative believes may affect the ability of the subject to complete the study or the interpretation of the results.
研究者
相似试验
已完成
4 期
A clinical trial to study the effects of two drugs, Metformin Immediate Release and Metformin Extended Release in newly diagnosed type 2 diabetes mellitus patients.CTRI/2021/04/033194Bangalore Medical College and Research Institute70
招募中
3 期
Metformin and Body Mass Index of Patients under Treatment with SSRICondition 1: Obesity. Condition 2: Depression. Condition 3: Anxiety Disorders.Drug-induced obesityMajor depressive disorder, single episode, severe without psychotic featuresOther anxiety disordersE66.1F32.2IRCT20140102016035N3Rasht University of Medical Sciences60
尚未招募
不适用
To evaluate the efficacy of two drugs methylprednisolone and etoricoxib in laproscopic surgeryCTRI/2019/03/018041Department of anaesthesiology Jln Medical College ajmer
已完成
3 期
Effect of methylene blue on treatment of COVID-19 patientsIRCT20191228045924N1Mashhad University of Medical Sciences80
已完成
2 期
Comparison between the effectiveness of methadone & Acceptance & Commitment group combination therapy & methadone therapy in the prevention rate of relapse in people with opium abuse.Mental & behavioural disorders due to use of opioids.Mental and behavioural disorders due to use of opioidsIRCT2016062328603N1Vice chancellor for research Zanjan University of Medical Sciences30